1.One-Stage Off-Pump CABG and Y Graft Replacement of the Abdominal Aorta in a Patient with Ischemic Heart Disease and Leriche's Syndrome
Toru Mizumoto ; Katsutoshi Adachi ; Katsumoto Hatanaka
Japanese Journal of Cardiovascular Surgery 2004;33(6):410-413
A 68-year-old man with unstable angina after old myocardial infarction, and Leriche's syndrome was admitted. Coronary angiography found 90% stenosis of the left anterior descending artery (LAD), 99% stenosis of the diagonal branch, 99% stenosis of the right coronary artery (RCA), and 90% stenosis of the 4-posterior descending branch (4 PD). Left circumflex artery (LCX) was diffusely stenotic and small. Aortography revealed complete occlusion of the infrarenal aorta. Due to the risk of limb-threatening ischemia, we planned simultaneous revascularization of myocardium and the lower extremities. Off-pump coronary artery bypass (OPCAB) was performed first. Subsequently Y graft replacement of abdominal aorta was completed. The postoperative course was uneventful and he was discharged on the 14th day after operation.
2.A Case of 1-Stage Replacement of the Ascending Aorta, Coronary Artery Bypass Grafting and Revascularization of the Lower Extremities
Toru Mizumoto ; Katsutoshi Adachi ; Katsumoto Hatanaka ; Toshihiko Kinoshita
Japanese Journal of Cardiovascular Surgery 2003;32(6):355-357
An 86-year-old woman was transferred to our hospital because of chest pain and left incomplete paralysis. CT-scan revealed a dissecting aortic aneurysm (DeBakey type 2) 6cm in diameter. Coronary angiography and aortography were perfomed to assess the coronary artery disease and ASO, they showed occluded LAD, 90% stenosis of CX and occluded left external iliac artery. We planned a 1-stage operation. Coronary artery bypass grafting with the beating heart was carried out prior to replacement of the ascending aorta. Then we performed femoro-femoro bypass. The postoperative course was uneventful and the patient was discharged 23 days after the operation.
3.A Case of One-Stage Surgery for Abdominal Aortic Aneurysm, Arch Aneurysm and Coronary Artery Disease
Katsutoshi Adachi ; Toru Mizumoto ; Katsumoto Hatanaka ; Iwao Hioki
Japanese Journal of Cardiovascular Surgery 2004;33(4):302-305
A 71-year-old man was transferred to our hospital because of impending rupture of an abdominal aortic aneurysm (AAA). Preoperative CT scan demonstrated a huge aneurysm of the aortic arch (TAA) associated with an AAA. Emergency coronary angiography revealed 3-vessel disease. One-stage surgery including TAA repair, coronary bypass surgery, and AAA repair was performed to avoid the possibility of rupture of the remaining aneurysms and the risk of ischemic heart diseases. One-stage surgery is a possible approach for patients with severe multivascular diseases.
4.Galenical Studies of “Kuei-chih-fu-ling-wan”
Kazuo TORIIZUKA ; Katsutoshi TERASAWA ; Seiichi HONMA ; Isao ADACHI ; Teruaki NAKAGAWA ; Isamu HORIKOSHI
Kampo Medicine 1984;35(3):185-189
5.A Case of Abdominal Aortic Pseudoaneurysm due to Extracorporeal Shock Wave Lithotripsy.
Koji Hirano ; Katsutoshi Adachi ; Hironori Tenpaku ; Tomoaki Sato ; Toshiya Sasaki ; Isao Yada
Japanese Journal of Cardiovascular Surgery 2003;32(2):116-119
Extracorporeal shock wave lithotripsy (ESWL) represents the preferred treatment for most upper ureteric and renal calculi. Complication rates associated with ESWL are low, justifying the enthusiasm and acceptance of this treatment modality. We report a case of abdominal aortic pseudoaneurysm due to ESWL. A 47-year-old man had undergone ESWL treatment for ureteric calculi since 1990. He was admitted to our hospital because of lumbar pain. Physical examination revealed a pulsatile mass in his abdomen. Abdominal CT scan showed an abdominal aortic aneurysm (5.3cm in diameter). Angiography showed a fusiform aneurysm of the infrarenal abdominal aorta. Y-graft replacement was performed after aneurysm resection. Histological examination revealed that it was a pseudoaneurysm. The patient had no history of trauma, inflammation or operation except ESWL. This is the first report of abdominal aortic pseudoaneurysm due to ESWL.
6.A Case Report of Mitral Valve Replacement for the Patient with Severely Calcified Mitral Annulus after Long-Term Hemodialysis
Katsutoshi Adachi ; Tomoaki Sato ; Hironori Tenpaku ; Masaki Kajimoto ; Shigeyuki Makino ; Koji Hirano ; Jin Tanaka ; Yukikatsu Okada
Japanese Journal of Cardiovascular Surgery 2003;32(5):293-296
A 53-year-old woman underwent mitral valve replacement for congestive heart failure due to mitral stenosis and regurgitation. She had been receiving hemodialysis because of diabetic nephropathy since 1993, and had had congestive heart failure since 1999. Echocardiography demonstrated mitral stenosis (MVA; 1.10cm2) and regurgitation with a severely calcified mitral annulus. Annular calcification extended to the posterior wall of the left ventricle and the base of bilateral papillary muscles. After removing all calcium from the mitral annulus to the base of the papillary muscle, the left ventricular posterior wall and mitral annulus were reconstructed by glutaraldehyde-preserved autologous pericardium. Then, a Carbo-Medics mechanical valve was placed at the mitral annulus using everting mattress sutures. Although her hemodynamics were stable, bacteremia and multi-organ failure developed 3 months after surgery and she died. Autopsy showed that the reconstructed left ventricular posterior wall and mitral annulus using glutaraldehyde preserved autologous pericardium were in excellent condition without any thrombus. No dehiscence was found at the suture line of the mechanical valve. Mitral annulus reconstruction with glutaraldehyde preserved autologous pericardium is thought to be effective for patients with calcified mitral annulus who require mitral valve surgery.
7.Attitude Survey about Adverse Drug Reactions Relief System for Pharmacists of Insurance Dispensing Pharmacies and Examination of Its Problems
Shigeo AKIYAMA ; Nobuyuki DOI ; Miyoko ASANO ; Shigeyasu FUKUZUMI ; Shingo TAKAHASHI ; Katsutoshi SUZUKI ; Kenji OGAWA ; Etsuko MIYAMOTO
Japanese Journal of Drug Informatics 2020;22(2):101-107
Objectives: “Adverse Drug Reaction Relief System” (hereinafter called the Relief System) has been established to provide prompt relief to patients experiencing health damage caused by adverse drug reactions. Since 2018, the Relief System has required community pharmacies that acquire additional points as local support system to actively report adverse drug reactions. Here, we investigated the recognition and utilization of the relief system among community pharmacists.Method: A questionnaire survey was conducted among community pharmacists between August 1 and September 30, 2019.Results: The survey achieved a response rate of 58.1%. The recognition rates of the relief system and Pharmaceuticals and Medical Devices Agency (PMDA) as its application destination were 98.9 and 74.5%, respectively. Of the community pharmacists, 2.6% had experience in utilizing the relief system; and 8.8% did not want to recommend the utilization of the relief system for patients mainly because of the “low recognition of the system” and “the complicated and troublesome preparation of the necessary documents such as medical certificates.” The community pharmacists who acquire additional points as local support system, compared with those who do not, achieved significantly higher rates in two items, including that for preparation of the documented procedures pertaining to adverse drug reactions.Conclusion: Despite the high recognition of the relief system among community pharmacists, the percentage of pharmacists with experience in actually utilizing the relief system and applying to the PMDA was low. One reason that the use of the relief system was not widespread was the low recognition particularly of the destination and procedures of reports on adverse drug reactions. In the future, educational campaigns to improve pharmacists’ comprehension of the relief system will be needed. Moreover, pharmacists must play a central role in enhancing the recognition of the public relief system and promoting medical safety.